Page 5 - Read Online
P. 5
9 The interplay between direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C
Sun Hong Yoo, Jung Hyun Kwon
Hepatoma Res 2020;6:9 http://dx.doi.org/10.20517/2394-5079.2019.49
10 Microwave ablation of hepatocellular carcinomas in octogenarians
Jacob Freedman
Hepatoma Res 2020;6:10 http://dx.doi.org/10.20517/2394-5079.2019.32
11 Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series
Cem Simsek, Amy Kim, Michelle Ma, Nilay Danis, Merve Gurakar, Andrew M. Cameron, Benjamin Philosophe,
Jacqueline Garonzik-Wang, Shane Ottmann, Ahmet Gurakar, Behnam Saberi
Hepatoma Res 2020;6:11 http://dx.doi.org/10.20517/2394-5079.2019.51
12 Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus
eradication with direct-acting antivirals
Takao Shimizu, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Sakura Kirino, Keiya Watakabe, Leona
Osawa, Mao Okada, Wan Wang, Mayu Higuchi, Kenta Takaura, Shun Kaneko, Nobuharu Tamaki, Hiroyuki
Nakanishi, Jun Itakura, Yuka Takahashi, Tadakazu Hisamatsu, Namiki Izumi
Hepatoma Res 2020;6:12 http://dx.doi.org/10.20517/2394-5079.2019.48
13 Prehabilitation in elderly patients scheduled for liver resection and protocol for Recovery Of Surgery in
Elderly
Ramkumar Mohan, Cheong Wei Terence Huey, Sameer Junnarkar, Jee Keem Low, Vishal G. Shelat
Hepatoma Res 2020;6:13 http://dx.doi.org/10.20517/2394-5079.2019.53
14 Ion channels in liver diseases and hepatocellular carcinoma: potential tools for diagnosis, prognosis, and
therapy
María de Guadalupe Chávez-López, Andrea Cruz-Díaz, Karla Nicol Tlapalcoyoa-Apanco, Julio Isael Pérez-
Carreón, Javier Camacho
Hepatoma Res 2020;6:14 http://dx.doi.org/10.20517/2394-5079.2019.023
15 Cytotoxic immune cell-based immunotherapy for hepatocellular carcinoma
Jing Li, Longxiang Tao, Xuefu Wang
Hepatoma Res 2020;6:15 http://dx.doi.org/10.20517/2394-5079.2019.34
16 Treatment efficacy for patients with chronic hepatitis C and preexisting hepatocellular carcinoma by directly
acting antivirals
Chia-Yen Dai, Chung-Feng Huang, Meng-Hsuan Hsieh, Ching-I Huang, Ming-Lun Yeh, Pei-Chien Tsai, Ching-Chih
Lin, Meng-Szu Lee, Jeng-Fu Yang, Po-Yao Hsu, Yu-Ju Wei, Cheng-Ting Hsu, Po-Cheng Liang, Yi-Hung Lin, Jee-Fu
Huang, Wan-Long Chuang, Ming-Lung Yu
Hepatoma Res 2020;6:16 http://dx.doi.org/10.20517/2394-5079.2019.40
17 Direct acting antivirals therapy and hepatocellular carcinoma risk in patients with hepatitis C virus
Monika Pazgan-Simon
Hepatoma Res 2020;6:17 http://dx.doi.org/10.20517/2394-5079.2019.52
